简介 联系方式 药物互相作用: 390 212
根据名称进行药物检索

Clomipramine 与 Vanquish

Clomipramine 与 Vanquish互相作用以及同时服用的可能性。

检测结果:
Clomipramine <> Vanquish
现实性: 27.11.2023 评论家: 医学副博士Shkutko P.M., in

在该服务的官方手册中,已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果,或起到良好效果。具体联合用药问题,需遵从医嘱。

用户:

使用氯一起与阿司匹林可以增加出血的风险。 交互作用更有可能如果你是老年人或有肾脏和肝脏疾病。 谈谈你的医生如果你有任何疑问或关切的问题。 你的医生可能已经知道的风险,但是已确定这是最好的治疗并采取适当的预防措施和监控你的密切对任何潜在并发症。 你应该立即寻求医疗照顾,如果你遇到任何不寻常的出血或青肿,或有其他迹象和症状的流血,例如头晕;头晕;红或黑,迟延便;咳或新鲜的呕吐或者干的血看起来像咖啡的理由;严重头痛;和弱点。 重要的是要告诉你的医生关于所有其他药物的使用,包括维生素和草药。 不停止使用任何药物,没有第一个说你的医生。

医界专家:

监测血清素再吸收抑制剂(SRIs)可以增强出血的危险在患者治疗溃疡的药剂和药剂的影响止血等抗凝血剂、血小板抑制剂、凝血酶抑制剂、溶解血栓剂、或代理人,通常会导致血小板减少。 三环抗抑郁药,氯,也是一个强斯里兰卡和可相互作用类似。 释放血清素的血小板中发挥着重要作用止血,因此SRIs可能改变血小板的功能和诱导出血。 公布的情况报告已经记录发生的流血事件患者治疗与精神药剂的干扰血清素再吸收的. 流血事件有关的SRIs有从瘀斑、血肿、鼻出血和瘀斑到威胁生命的出血. 更多的流行病学研究已经证实之间的关联使用的这些药的发生和上消化道出血,并同时使用非甾体抗炎药或阿司匹林是找到加强的风险。 初步数据还表明,可能还有一个药效动力学之间的互动Ssri和口服抗凝血剂,可能会导致增加流血的素质。 伴随政府的帕罗西汀和华法林,具体地说,已经与相关的频率增加的流血没有明显的变化,在处理或药物或变化的凝血酶原时间。 出血也报告了氟西汀和华法林,而游离和舍曲林已经报道了延长的凝血酶原时间的病人把药物约5%到8%。 在所依赖的研究报告(随机评估的长期抗凝血剂治疗),SRIs是相关联的风险增加出血在所有治疗的群体。

管理:谨慎建议,如果SRIs或氯都结合使用其他药物影响止血。 靠近临床和实验室观察对于血液的并发症的建议。 患者应立即报告任何出血的迹象到他们的医生,包括疼痛、肿、头疼、头晕、弱点、出血时间延长,从削减,增加经流,阴道出血、流鼻血,止血的牙龈刷、不寻常或出血瘀伤、红色或棕色的尿液或红色或黑色的大便。

来源
  • Krivy J, Wiener J "Sertraline and platelet counts in idiopathic thrombocytopenia purpura." Lancet 345 (1995): 132
  • "Product Information. Savella (milnacipran)." Forest Pharmaceuticals, St. Louis, MO.
  • Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6
  • Ottervanger JP, Stricker BH, Huls J, Weeda JN "Bleeding attributed to the intake of paroxetine." Am J Psychiatry 151 (1994): 781-2
  • Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30
  • Cerner Multum, Inc. "Australian Product Information." O 0
  • "Product Information. Paxil (paroxetine)." GlaxoSmithKline, Research Triangle Park, NC.
  • "Product Information. Prozac (fluoxetine)." Dista Products Company, Indianapolis, IN.
  • de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S "Intracranial haemorrhage and use of selective serotonin reuptake inhibitors." Br J Clin Pharmacol 50 (2000): 43-7
  • Alderman CP, Moritz CK, Ben-Tovim DI "Abnormal platelet aggregation associated with fluoxetine therapy." Ann Pharmacother 26 (1992): 1517-9
  • de Maistre E, Allart C, Lecompte T, Bollaert PE "Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors." Am J Med 113 (2002): 530-2
  • Claire RJ, Servis ME, Cram DL Jr "Potential interaction between warfarin sodium and fluoxetine." Am J Psychiatry 148 (1991): 1604
  • Pai VB, Kelly MW "Bruising associated with the use of fluoxetine." Ann Pharmacother 30 (1996): 786-8
  • Ciraulo DA, Shader RI "Fluoxetine drug-drug interactions. II." J Clin Psychopharmacol 10 (1990): 213-7
  • "Product Information. Lexapro (escitalopram)." Forest Pharmaceuticals, St. Louis, MO.
  • "Product Information. Fetzima (levomilnacipran)." Forest Pharmaceuticals, St. Louis, MO.
  • Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ "Fluoxetine and bleeding in obsessive-compulsive disorder." Am J Psychiatry 148 (1991): 949
  • Alderman CP, Seshadri P, Ben-Tovim DI "Effects of serotonin reuptake inhibitors on hemostasis." Ann Pharmacother 30 (1996): 1232-4
  • Dent LA, Orrock MW "Warfarin-fluoxetine and diazepam-fluoxetine interaction." Pharmacotherapy 17 (1997): 170-2
  • "Product Information. Effexor (venlafaxine)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  • Humphries JE, Wheby MS, VandenBerg SR "Fluoxetine and the bleeding time." Arch Pathol Lab Med 114 (1990): 727-8
  • Woolfrey S, Gammack NS, Dewar MS, Brown PJ "Fluoxetine-warfarin interaction." BMJ 307 (1993): 241
  • "Product Information. Pristiq (desvenlafaxine)." Wyeth Laboratories, Philadelphia, PA.
  • Messiha FS "Fluoxetine - adverse effects and drug-drug interactions." J Toxicol Clin Toxicol 31 (1993): 603-30
  • "Product Information. Celexa (citalopram)." Forest Pharmaceuticals, St. Louis, MO.
  • Ford MA, Anderson ML, Rindone JP, Jaskar DW "Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin." J Clin Psychopharmacol 17 (1997): 110-2
  • "Product Information. Zoloft (sertraline)." Roerig Division, New York, NY.
  • Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6
  • Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH "Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study." Arch Intern Med 163 (2003): 59-64
  • "Product Information. Cymbalta (duloxetine)." Lilly, Eli and Company, Indianapolis, IN.
  • Aranth J, Lindberg C "Bleeding, a side effect of fluoxetine." Am J Psychiatry 149 (1992): 412
  • Layton D, Clark DWJ, Pearce GL, Shakir SAW "Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England." Eur J Clin Pharmacol 57 (2001): 167-76
  • "Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc, Marietta, GA.
  • Leung M, Shore R "Fluvoxamine-associated bleeding." Can J Psychiatry 41 (1996): 604-5
  • Tata LJ, Fortun PJ, Hubbard RB, et al. "Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?" Aliment Pharmacol Ther 22 (2005): 175-81
  • "Product Information. Brintellix (vortioxetine)." Takeda Pharmaceuticals America, Lincolnshire, IL.
  • Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B "Paroxetine decreases platelet serotonin storage and platelet function in human beings." Clin Pharmacol Ther 68 (2000): 435-42
  • de Abajo FJ, Rodriguez LA, Montero D "Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study." BMJ 319 (1999): 1106-9
  • "Product Information. Viibryd (vilazodone)." Trovis Pharmaceuticals LLC, New Haven, CT.
Clomipramine

非专利名称: clomipramine

品牌: Anafranil

同义词: ClomiPRAMINE

Vanquish

非专利名称: acetaminophen / aspirin / caffeine

品牌: Excedrin, Vanquish, Anacin Advanced Headache Formula, Arthriten, Backaid IPF, Goodys Extra Strength, Goody's Headache Powders, Pain Reliever Plus, Pamprin Max, Uricalm Intensive, Genace, Excedrin Geltab, Supac, Excedrin Migraine, Excedrin Extra Strength, Excedrin Extra Strength Geltab, Excedrin Migraine Geltab, Excedrin Express, Excedrin Menstrual Express, Bayer Migraine Formula, Goodys Headache Powders

同义词:

在药物相容性与互相作用的检测过程中使用下列的信息来源:Drugs.com, Rxlist.com, Webmd.com, Medscape.com。

与食物,生活方式相互作用
与疾病相互作用